453 related articles for article (PubMed ID: 31605710)
1. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
2. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.
Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M
J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.
Wang Y; Xu P; Yao J; Yang R; Shi Z; Zhu X; Feng X; Gao S
Target Oncol; 2016 Apr; 11(2):197-207. PubMed ID: 26408293
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
[TBL] [Abstract][Full Text] [Related]
6. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.
Wang LB; Feng L; He J; Liu B; Sun JG
Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596
[No Abstract] [Full Text] [Related]
7. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
[TBL] [Abstract][Full Text] [Related]
8. miR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer.
Rahbari R; Rahimi K; Rasmi Y; Khadem-Ansari MH; Abdi M
Arch Med Res; 2022 Jul; 53(5):483-491. PubMed ID: 35840467
[TBL] [Abstract][Full Text] [Related]
9. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
10. miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by targeting RAGE.
Luo T; Yan Y; He Q; Ma X; Wang W
Oncol Rep; 2018 Jun; 39(6):2906-2914. PubMed ID: 29620238
[TBL] [Abstract][Full Text] [Related]
11. miR-211-5p is down-regulated and a prognostic marker in bladder cancer.
Wang W; Liu Z; Zhang X; Liu J; Gui J; Cui M; Li Y
J Gene Med; 2020 Dec; 22(12):e3270. PubMed ID: 32893379
[TBL] [Abstract][Full Text] [Related]
12. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
[TBL] [Abstract][Full Text] [Related]
13. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-216b targets
Liu T; Ye P; Ye Y; Han B
Int J Biol Sci; 2021; 17(11):2970-2983. PubMed ID: 34345220
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-138-5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis.
Rasoolnezhad M; Safaralizadeh R; Hosseinpourfeizi MA; Banan-Khojasteh SM; Baradaran B
Eur J Pharmacol; 2021 Apr; 896():173933. PubMed ID: 33545160
[TBL] [Abstract][Full Text] [Related]
16. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.
Ma F; Zhang L; Ma L; Zhang Y; Zhang J; Guo B
J Exp Clin Cancer Res; 2017 Nov; 36(1):158. PubMed ID: 29132384
[TBL] [Abstract][Full Text] [Related]
17. Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development.
Ren W; Guan W; Zhang J; Wang F; Xu G
Aging (Albany NY); 2019 Apr; 11(7):2151-2176. PubMed ID: 30982780
[TBL] [Abstract][Full Text] [Related]
18. [LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression].
Yang C; Xue JG
Zhonghua Nan Ke Xue; 2023 Oct; 29(10):881-887. PubMed ID: 38639656
[TBL] [Abstract][Full Text] [Related]
19. miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R
J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690
[TBL] [Abstract][Full Text] [Related]
20. LncRNA KCNQ1OT1 acts as miR-216b-5p sponge to promote colorectal cancer progression via up-regulating ZNF146.
Zhu S; Chen CY; Hao Y
J Mol Histol; 2021 Jun; 52(3):479-490. PubMed ID: 33394291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
